LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences.

In the processes of carcinogenesis caused by genotoxic carcinogens, DNA-adduct formation and resultant genetic changes are crucially important. In this report, the relationship between DNA-adduct levels and mutant frequencies (MFs), DNA-adduct levels and cancer incidences, and MFs and cancer incidences induced by heterocyclic amines (HCAs), to which humans are exposed on daily basis were investigated. There was no direct correlation between adduct levels and MFs detected after feeding Big Blue mice with 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ), in a comparison among various organs. Further, there was no direct correlation between DNA-adduct levels and cancer incidences, in a comparison among various organs of F344 rats. Since DNA-adducts are fixed as mutations after cell proliferation, and mutations in cancer-related genes result in cancer development, it is expected that MFs directly correlate with cancer incidences. However, there was no direct correlation between MFs and cancer incidences. Possible mechanisms involved in the discordance between DNA damage markers and cancer incidences are discussed.

[1]  T. Sugimura,et al.  DNA adduct level induced by 2-amino-3,4-dimethylimidazo[4,5-f]-quinoline in Big Blue mice does not correlate with mutagenicity. , 1998, Mutagenesis.

[2]  J. Tucker,et al.  Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino(alpha)carboline. , 1996, Carcinogenesis.

[3]  J. Weaver,et al.  32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. , 1985, Carcinogenesis.

[4]  D W Gaylor,et al.  Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment. , 1998, Environmental health perspectives.

[5]  S. Thorgeirsson,et al.  Lack of Carcinogenicity of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx) in Cynomolgus Monkeys , 1999, Japanese journal of cancer research : Gann.

[6]  T. Sugimura,et al.  DNA Modification by 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine in Rats , 1989, Japanese journal of cancer research : Gann.

[7]  N Ito,et al.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. , 1997, Cancer research.

[8]  T. Sugimura,et al.  How we should deal with unavoidable exposure of man to environmental mutagens: cooked food mutagen discovery, facts and lessons for cancer prevention. , 2000, Mutation research.

[9]  M. Nagao,et al.  A new approach to risk estimation of food-borne carcinogens--heterocyclic amines--based on molecular information. , 1999, Mutation research.

[10]  T. Sugimura,et al.  No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue mice. , 1998, Mutation research.

[11]  D. Phillips,et al.  Tissue distribution of DNA adducts in CDF1 mice fed 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ). , 1990, Carcinogenesis.

[12]  C. Potten,et al.  Stem cells: the intestinal stem cell as a paradigm. , 2000, Carcinogenesis.

[13]  H. Kataoka,et al.  Determination of Mutagenic Heterocyclic Amines in Combustion Smoke Samples , 1998, Bulletin of environmental contamination and toxicology.

[14]  H. Bartsch,et al.  Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. , 1994, Chemical research in toxicology.

[15]  L. Boldrini,et al.  Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/Mex+ transfected cells to mitozolomide. , 1996, Carcinogenesis.

[16]  T. Mikami,et al.  Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse). , 1998, Mutation research.

[17]  J. Short,et al.  Transgenic systems for in vivo mutation analysis. , 1993, Mutation research.

[18]  G. R. Stuart,et al.  Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene. , 1997, Mutation research.

[19]  M A Butler,et al.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  N Ito,et al.  A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1991, Carcinogenesis.

[21]  K T Bogen,et al.  Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. , 1995, Carcinogenesis.

[22]  H. Bartsch,et al.  Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis. , 1995, Princess Takamatsu symposia.

[23]  T. Sugimura,et al.  Detection of Guanine‐C8‐2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine Adduct as a Single Spot on Thin‐layer Chromatography by Modification of the 32P‐Postlabeling Method , 1994, Japanese journal of cancer research : Gann.

[24]  T. Sugimura,et al.  A new modification of the 32P-post-labeling method to recover IQ-DNA adducts as mononucleotides. , 1999, Mutagenesis.

[25]  T. Sugimura,et al.  DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. , 1996, Carcinogenesis.

[26]  M. Toyota,et al.  Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Sugimura,et al.  Identification of N-(deoxyguanosin-8-yl)-2-amino-3,4-dimethylimidazo[4,5-f]quinoline (dG-C8-MeIQ) as a major adduct formed by MeIQ with nucleotides in vitro with DNA in vivo. , 1994, Carcinogenesis.